| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Channing Laboratory, Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts 02115 [E. G., E. B. R., G. A. C., M. J. S., W. C. W.], and Departments of Nutrition [E. G., M. L., E. B. R., M. J. S., W. C. W.] and Epidemiology [E. G., D. S., E. B. R., G. A. C., M. J. S., W. C. W.], Harvard School of Public Health, Boston, Massachusetts 02115
Because the role of exercise in prostate cancer is unclear, we examined the relationship between leisure time physical activity and risk of prostate cancer in the Health Professionals Follow-up Study, a prospective cohort study of male health professionals in the United States. In 1986, 47,542 men 4075 years of age and free of cancer responded to a mailed questionnaire that included an assessment of physical activity. The reported average time per week spent on each of a variety of nonoccupational activities was multiplied by its typical energy expenditure requirements expressed in metabolic equivalents (METs) and summed to yield a total weekly MET-hour score. We also examined MET-hours from all vigorous activities, defined as those requiring energy expenditures of six or more METs, and nonvigorous activities. From 1986 until January 31, 1994, we identified 1362 incident cases of total prostate cancer (excluding stage A1), 419 advanced (extraprostatic) cases, and 200 metastatic cases. No relationship with total or advanced prostate cancer was evident for total, vigorous, and nonvigorous physical activity. For metastatic prostate cancer, we also found no linear trends for these activities, but did observe a significantly lower risk in the highest category of vigorous activity (multivariate relative risk = 0.46; 95% confidence interval = 0.240.89 for >25 versus 0 MET-hours), controlling for age, vasectomy, history of diabetes, height, smoking, and dietary factors. This highest category included 15% of the population and reflects at least 3 h/week of participation in vigorous activities. Differences in disease surveillance according to activity level could not account for our findings. The results from this cohort indicate that physical activity is unlikely to influence the incidence of total prostate cancer appreciably; however, the suggestion of a lower risk of metastatic prostate cancer in men engaging in high levels of vigorous activities warrants further study.
1 Supported by Grants CA 55075 and HL 35464 from the National Institutes of Health.
2 To whom requests for reprints should be addressed, at Channing Laboratory, 181 Longwood Avenue, Boston, MA 02115. Phone: 617-432-4648; Fax: 617-432-2435; E-mail: Edward.Giovannucci@channing.harvard.edu.
Received 5/22/98. Accepted 9/14/98.
This article has been cited by other articles:
![]() |
R. F. Zoeller Jr Lifestyle in the Prevention and Management of Cancer: Physical Activity American Journal of Lifestyle Medicine, September 1, 2009; 3(5): 353 - 361. [Abstract] [PDF] |
||||
![]() |
A. J. Lanou Should dairy be recommended as part of a healthy vegetarian diet? Counterpoint Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1638S - 1642S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Moore, T. M. Peters, J. Ahn, Y. Park, A. Schatzkin, D. Albanes, R. Ballard-Barbash, A. Hollenbeck, and M. F. Leitzmann Physical Activity in Relation to Total, Advanced, and Fatal Prostate Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2458 - 2466. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Schnohr, M. Gronbaek, L. Petersen, H. Ole Hein, and T. Ia Sorensen Physical activity in leisure-time and risk of cancer: 14-year follow-up of 28,000 Danish men and women Scand J Public Health, August 1, 2005; 33(4): 244 - 249. [Abstract] [PDF] |
||||
![]() |
M. P.A. Zeegers, M. J.M. Dirx, and P. A. van den Brandt Physical Activity and the Risk of Prostate Cancer in The Netherlands Cohort Study, Results after 9.3 Years of Follow-up Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1490 - 1495. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Giovannucci, Y. Liu, M. F. Leitzmann, M. J. Stampfer, and W. C. Willett A Prospective Study of Physical Activity and Incident and Fatal Prostate Cancer Arch Intern Med, May 9, 2005; 165(9): 1005 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Patel, C. Rodriguez, E. J. Jacobs, L. Solomon, M. J. Thun, and E. E. Calle Recreational Physical Activity and Risk of Prostate Cancer in a Large Cohort of U.S. Men Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 275 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Friedenreich, S. E. McGregor, K. S. Courneya, S. J. Angyalfi, and F. G. Elliott Case-Control Study of Lifetime Total Physical Activity and Prostate Cancer Risk Am. J. Epidemiol., April 15, 2004; 159(8): 740 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Platz, M. F. Leitzmann, D. S. Michaud, W. C. Willett, and E. Giovannucci Interrelation of Energy Intake, Body Size, and Physical Activity with Prostate Cancer in a Large Prospective Cohort Study Cancer Res., December 1, 2003; 63(23): 8542 - 8548. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tanasescu, M. F. Leitzmann, E. B. Rimm, and F. B. Hu Physical Activity in Relation to Cardiovascular Disease and Total Mortality Among Men With Type 2 Diabetes Circulation, May 20, 2003; 107(19): 2435 - 2439. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J Varo, M. A Martinez-Gonzalez, J. de Irala-Estevez, J. Kearney, M. Gibney, and J A. Martinez Distribution and determinants of sedentary lifestyles in the European Union Int. J. Epidemiol., February 1, 2003; 32(1): 138 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Friedenreich and M. R. Orenstein Physical Activity and Cancer Prevention: Etiologic Evidence and Biological Mechanisms J. Nutr., November 1, 2002; 132(11): 3456S - 3464. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Friedenreich Physical Activity and Cancer Prevention: From Observational to Intervention Research Cancer Epidemiol. Biomarkers Prev., April 1, 2001; 10(4): 287 - 301. [Abstract] [Full Text] |
||||
![]() |
J. V Lacey Jr, J. Deng, M. Dosemeci, Y.-T. Gao, F. Mostofi, I. A Sesterhenn, T. Xie, and A. W Hsing Prostate cancer, benign prostatic hyperplasia and physical activity in Shanghai, China Int. J. Epidemiol., April 1, 2001; 30(2): 341 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Stattin, S. Söderberg, G. Hallmans, A. Bylund, R. Kaaks, U.-H. Stenman, A. Bergh, and T. Olsson Leptin Is Associated with Increased Prostate Cancer Risk: A Nested Case-Referent Study J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1341 - 1345. [Abstract] [Full Text] |
||||
![]() |
E. A. Platz, E. B. Rimm, W. C. Willett, P. W. Kantoff, and E. Giovannucci Racial Variation in Prostate Cancer Incidence and in Hormonal System Markers Among Male Health Professionals J Natl Cancer Inst, December 20, 2000; 92(24): 2009 - 2017. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Bosland Chapter 2: The Role of Steroid Hormones in Prostate Carcinogenesis J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 39 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liu, I-M. Lee, P. Linson, U. Ajani, J. E Buring, and C. H Hennekens A prospective study of physical activity and risk of prostate cancer in US physicians Int. J. Epidemiol., February 1, 2000; 29(1): 29 - 35. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |